Compare $LUNG vs $OM | Chartloom

Compare

$LUNG vs $OM

Pulmonx Corp · Outset Medical Inc

LUNG

Pulmonx Corp

Outset Medical Inc

Compare $LUNG vs $OM

Comparing Pulmonx Corp and Outset Medical Inc

LUNGPulmonx Corp

OMOutset Medical Inc

LUNGPulmonx Corp

Market cap

$78M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.80x

Rev growth (TTM)

-3.4%

YTD performance

-20.0%

52W performance

3.4%

FCF yield

-39.5%

OMOutset Medical Inc

Market cap

$75M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.56x

Rev growth (TTM)

-1.3%

YTD performance

9.5%

52W performance

-74.4%

FCF yield

-51.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LUNG

Detailed metrics comparison

LUNG

Pulmonx Corp

Outset Medical Inc

Market Cap

LUNG$78M

OM$75M

Enterprise Value

LUNG$59M

OM$138M

Price

LUNG$1.84

OM$4.05

P/E Ratio

LUNGN/A

OMN/A

P/S Ratio

LUNG0.89x

OM0.64x

EV/Sales

LUNG0.68x

OM1.17x

EV/EBITDA

LUNG0.00x

OM0.00x

P/B Ratio

LUNG2.01x

OM0.77x

P/FCF Ratio

LUNGN/A

OMN/A

EV/FCF

LUNG-1.94x

OM-3.56x

PEG Ratio

LUNGN/A

OMN/A

Forward P/E (NTM)

LUNGN/A

OMN/A

Forward P/S (NTM)

LUNG0.80x

OM0.56x

Revenue (TTM)

LUNG$87M

OM$118M

Revenue Growth (YoY)

LUNG-3.4%

OM-1.3%

Forward Rev Growth

LUNG8.5%

OM10.5%

Gross Margin (TTM)

LUNG77.1%

OM41.8%

Operating Margin (TTM)

LUNG0.0%

OM0.0%

EBITDA Margin (TTM)

LUNG-49.7%

OM-53.2%

Net Margin (TTM)

LUNG-55.0%

OM-63.1%

FCF Margin (TTM)

LUNG-35.1%

OM-33.0%

Net Income (TTM)

LUNG$-48M

OM$-74M

FCF (TTM)

LUNG$-31M

OM$-39M

EPS (TTM)

LUNG-$1.13

OM-$3.99

ROE (TTM)

LUNG-9666.0%

OM-6225.0%

ROA (TTM)

LUNG-3832.0%

OM-2875.0%

ROIC (TTM)

LUNG-5528.0%

OM-3438.0%

Cash

LUNG$56M

OM$35M

Debt

LUNG$38M

OM$98M

Net Cash/Debt

LUNG$18M

OM$-63M

Current Ratio (TTM)

LUNG4.32x

OM5.19x

Quick Ratio (TTM)

LUNG3.37x

OM4.02x

Debt/Equity (TTM)

LUNG0.96x

OM1.02x

Debt/Assets (TTM)

LUNG0.0%

OM0.0%

Interest Coverage (TTM)

LUNGN/A

OMN/A

Net Debt/EBITDA (TTM)

LUNG0.00x

OM0.00x

Beta

LUNG0.27

OM2.01

52W Performance

LUNG3.4%

OM-74.4%

YTD Performance

LUNG-20.0%

OM9.5%

% from 52W High

LUNG-36.3%

OM-74.9%

% from 52W Low

LUNG62.8%

OM42.6%

Asset Turnover (TTM)

LUNG0.70x

OM0.46x

FCF Yield (TTM)

LUNG-39.5%

OM-51.8%

Earnings Yield (TTM)

LUNG-61.9%

OM-98.9%

Dividend Yield (TTM)

LUNGN/A

OMN/A

Rule of 40

LUNG-38.5

OM-34.3

EV/GP/RG

LUNG0.08

OM0.04

Ticker research

View LUNG research View OM research

Metric	LUNG Pulmonx Corp	OM Outset Medical Inc
Market & Valuation
Market Cap	$78M	$75M
Enterprise Value	$59M	$138M
Price	$1.84	$4.05
P/E Ratio	N/A	N/A
P/S Ratio	0.89x	0.64x
EV/Sales	0.68x	1.17x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.01x	0.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.94x	-3.56x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.80x	0.56x
Revenue & Growth
Revenue (TTM)	$87M	$118M
Revenue Growth (YoY)	-3.4%	-1.3%
Forward Rev Growth	8.5%	10.5%
Profitability
Gross Margin (TTM)	77.1%	41.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-49.7%	-53.2%
Net Margin (TTM)	-55.0%	-63.1%
FCF Margin (TTM)	-35.1%	-33.0%
Net Income (TTM)	$-48M	$-74M
FCF (TTM)	$-31M	$-39M
EPS (TTM)	-$1.13	-$3.99
ROE (TTM)	-9666.0%	-6225.0%
ROA (TTM)	-3832.0%	-2875.0%
ROIC (TTM)	-5528.0%	-3438.0%
Financial Health
Cash	$56M	$35M
Debt	$38M	$98M
Net Cash/Debt	$18M	$-63M
Current Ratio (TTM)	4.32x	5.19x
Quick Ratio (TTM)	3.37x	4.02x
Debt/Equity (TTM)	0.96x	1.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.27	2.01
52W Performance	3.4%	-74.4%
YTD Performance	-20.0%	9.5%
% from 52W High	-36.3%	-74.9%
% from 52W Low	62.8%	42.6%
Efficiency & Yields
Asset Turnover (TTM)	0.70x	0.46x
FCF Yield (TTM)	-39.5%	-51.8%
Earnings Yield (TTM)	-61.9%	-98.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-38.5	-34.3
EV/GP/RG	0.08	0.04
Ticker research	View LUNG research	View OM research

Valuation

P/S Ratio

0.64x

LUNG

0.89x

EV/FCF

-3.56x

LUNG

-1.94x

Growth & revenue

Revenue Growth TTM

-1.3%

LUNG

-3.4%

Forward Revenue Growth

10.5%

LUNG

8.5%

Profitability & performance

Gross Margin

LUNG

77.1%

41.8%

ROE

-6225.0%

LUNG

-9666.0%

FCF Yield %

LUNG

-39.5%

-51.8%

52-Week Performance

LUNG

3.4%

-74.4%

Detailed metrics comparison

LUNG

Pulmonx Corp

Outset Medical Inc

Market Cap

LUNG$78M

OM$75M

Enterprise Value

LUNG$59M

OM$138M

Price

LUNG$1.84

OM$4.05

P/E Ratio

LUNGN/A

OMN/A

P/S Ratio

LUNG0.89x

OM0.64x

EV/Sales

LUNG0.68x

OM1.17x

EV/EBITDA

LUNG0.00x

OM0.00x

P/B Ratio

LUNG2.01x

OM0.77x

P/FCF Ratio

LUNGN/A

OMN/A

EV/FCF

LUNG-1.94x

OM-3.56x

PEG Ratio

LUNGN/A

OMN/A

Forward P/E (NTM)

LUNGN/A

OMN/A

Forward P/S (NTM)

LUNG0.80x

OM0.56x

Revenue (TTM)

LUNG$87M

OM$118M

Revenue Growth (YoY)

LUNG-3.4%

OM-1.3%

Forward Rev Growth

LUNG8.5%

OM10.5%

Gross Margin (TTM)

LUNG77.1%

OM41.8%

Operating Margin (TTM)

LUNG0.0%

OM0.0%

EBITDA Margin (TTM)

LUNG-49.7%

OM-53.2%

Net Margin (TTM)

LUNG-55.0%

OM-63.1%

FCF Margin (TTM)

LUNG-35.1%

OM-33.0%

Net Income (TTM)

LUNG$-48M

OM$-74M

FCF (TTM)

LUNG$-31M

OM$-39M

EPS (TTM)

LUNG-$1.13

OM-$3.99

ROE (TTM)

LUNG-9666.0%

OM-6225.0%

ROA (TTM)

LUNG-3832.0%

OM-2875.0%

ROIC (TTM)

LUNG-5528.0%

OM-3438.0%

Cash

LUNG$56M

OM$35M

Debt

LUNG$38M

OM$98M

Net Cash/Debt

LUNG$18M

OM$-63M

Current Ratio (TTM)

LUNG4.32x

OM5.19x

Quick Ratio (TTM)

LUNG3.37x

OM4.02x

Debt/Equity (TTM)

LUNG0.96x

OM1.02x

Debt/Assets (TTM)

LUNG0.0%

OM0.0%

Interest Coverage (TTM)

LUNGN/A

OMN/A

Net Debt/EBITDA (TTM)

LUNG0.00x

OM0.00x

Beta

LUNG0.27

OM2.01

52W Performance

LUNG3.4%

OM-74.4%

YTD Performance

LUNG-20.0%

OM9.5%

% from 52W High

LUNG-36.3%

OM-74.9%

% from 52W Low

LUNG62.8%

OM42.6%

Asset Turnover (TTM)

LUNG0.70x

OM0.46x

FCF Yield (TTM)

LUNG-39.5%

OM-51.8%

Earnings Yield (TTM)

LUNG-61.9%

OM-98.9%

Dividend Yield (TTM)

LUNGN/A

OMN/A

Rule of 40

LUNG-38.5

OM-34.3

EV/GP/RG

LUNG0.08

OM0.04

Ticker research

View LUNG research View OM research

Metric	LUNG Pulmonx Corp	OM Outset Medical Inc
Market & Valuation
Market Cap	$78M	$75M
Enterprise Value	$59M	$138M
Price	$1.84	$4.05
P/E Ratio	N/A	N/A
P/S Ratio	0.89x	0.64x
EV/Sales	0.68x	1.17x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.01x	0.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.94x	-3.56x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.80x	0.56x
Revenue & Growth
Revenue (TTM)	$87M	$118M
Revenue Growth (YoY)	-3.4%	-1.3%
Forward Rev Growth	8.5%	10.5%
Profitability
Gross Margin (TTM)	77.1%	41.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-49.7%	-53.2%
Net Margin (TTM)	-55.0%	-63.1%
FCF Margin (TTM)	-35.1%	-33.0%
Net Income (TTM)	$-48M	$-74M
FCF (TTM)	$-31M	$-39M
EPS (TTM)	-$1.13	-$3.99
ROE (TTM)	-9666.0%	-6225.0%
ROA (TTM)	-3832.0%	-2875.0%
ROIC (TTM)	-5528.0%	-3438.0%
Financial Health
Cash	$56M	$35M
Debt	$38M	$98M
Net Cash/Debt	$18M	$-63M
Current Ratio (TTM)	4.32x	5.19x
Quick Ratio (TTM)	3.37x	4.02x
Debt/Equity (TTM)	0.96x	1.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.27	2.01
52W Performance	3.4%	-74.4%
YTD Performance	-20.0%	9.5%
% from 52W High	-36.3%	-74.9%
% from 52W Low	62.8%	42.6%
Efficiency & Yields
Asset Turnover (TTM)	0.70x	0.46x
FCF Yield (TTM)	-39.5%	-51.8%
Earnings Yield (TTM)	-61.9%	-98.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-38.5	-34.3
EV/GP/RG	0.08	0.04
Ticker research	View LUNG research	View OM research